CannTrust Holdings Inc.

Most Recent

  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///Gross Income and EBITDA Estimates
    Miscellaneous

    Aurora Cannabis: Analysts’ Projections

    Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Markets Rebound but Cannabis Stock Performance Is Mixed

    Markets rebounded today after the recent sell-off fueled by US-China trade tensions.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///canopy
    Consumer

    Canopy Growth Stock Rises, Oppenheimer Initiates Coverage

    Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.

    By Sushree Mohanty
  • uploads///ebitda
    Real Estate

    Comparing the Valuation Multiples of Cannabis Stocks

    In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

    By Adam Jones
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///Canna
    Company & Industry Overviews

    Kamala Harris: Presidential Candidate for Legalizing Marijuana

    Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Cannabis Stocks Continue to Struggle on the Last Day of April

    The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.

    By Adam Jones
  • uploads///Cannabis
    Cannabis

    Cannabis Sector 2019 Review and 2020 Outlook

    Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Will Trump Have an Edge over Biden?

    With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: O’Rourke Blazes His 2020 Campaign

    Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, WEED, ACB, and CTST

    The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Valuation for Cannabis Stocks in October

    The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.

    By Margaret Patrick
  • uploads///marijuana
    Cannabis

    Marijuana: Why Is Washington Changing Its Laws?

    In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

    By Sushree Mohanty
  • uploads///canopy
    Cannabis

    Canopy Growth Gets an Upgrade, Constellation Books Losses

    Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”

    By Sushree Mohanty
  • uploads///CNTTF
    Company & Industry Overviews

    CannTrust Holdings’ Stock Grew ~11% Last Week

    On January 25, CannTrust Holdings’ (CNTTF) stock price closed at $6.87, ~5.19% higher than its closing price of $6.53 on January 24 and ~11% higher than its closing price of $6.21 on January 18.

    By Daniel Collins
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • uploads///cannabis stocks
    Cannabis

    Which Cannabis Stocks Have Lost More than 40% in 2019?

    The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.

    By Sushree Mohanty
  • uploads///Opioid
    Cannabis

    Opioid Crisis: Is Cannabis Legalization a Good Idea?

    According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.

    By Sirisha Bhogaraju
  • uploads///IIPR
    Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///TJX Sales
    Cannabis

    Aurora Cannabis: Target Price and Valuation Update

    So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]

    By Market Realist
  • uploads///Aphria
    Cannabis

    Aphria: Analysts’ Target Price and Ratings

    While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.

    By Sushree Mohanty
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What’s the Word on the Street?

    Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

    By Sushree Mohanty
  • uploads///cannabis
    Company & Industry Overviews

    Cannabis Stocks: Will Tough Times End Soon?

    Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

    By Sushree Mohanty
  • uploads///cannabis sector pitfalls
    Cannabis

    Coronavirus Revealed Cannabis Supply Chain’s Pitfalls

    The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain. 

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Regulators Beware: Cannabis Linked to Job Loss

    Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.

    By Sushree Mohanty
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    Cannabis Legalization: Dark Clouds Loom Post Debate

    Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

    By Sushree Mohanty
  • uploads///cannabis sales
    Cannabis

    Cannabis Sales Decline Across Canada—Why?

    In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.

    By Sushree Mohanty
  • uploads///Cannabis ETF Daily Performance
    Company & Industry Overviews

    Is Aurora Cannabis Looking at a Consumer Business Acquisition?

    Since Peltz has experience in the consumer market space, Aurora Cannabis is probably looking to make a deeper foray into the consumer space.

    By Adam Jones
  • uploads///Marijuana
    Cannabis

    Mississippi Lawmakers Make Marijuana Legalization Harder

    Mississippi has been trying to put a legalization initiative on the November ballot. However, lawmakers’ new strategy makes legalization difficult.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Exploring Canada’s Cannabis Demand-Supply Landscape

    Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

    By Sushree Mohanty
  • uploads///Jan_
    Cannabis

    Why Cannabis Stocks Are Falling Today

    Weakness in cannabis stocks continued today, the fourth day of decline. The US equity market fell today due to the growing tension between the US and Iran.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Why Is CannTrust Experiencing a Rally in 2020?

    CannTrust (CTST) stock has experienced a surprising turn of events in January. The stock has gained good upward momentum.

    By Adam Jones
  • uploads///can_
    Cannabis

    Cannabis Update: GTII, KSHB, IIPR, and CTST

    Today, the cannabis sector was trading in the red, with multiple ETFs losing ground. Here, we’ll have a look at cannabis stocks that are in the news today.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Why Republicans Don’t Push for Cannabis Legalization

    Marijuana legalization in the US remains in limbo. Most Democrats have endorsed marijuana legalization. However, Republicans have yet to embrace it fully.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    CannTrust Stock Fell 22% Due to New Information

    On Wednesday, CannTrust (CTST) stock fell almost 22.5% after new information came to light. The information came from a report by The Globe and Mail.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    CannTrust Lands in Hot Water Again

    The Canadian cannabis company CannTrust (CTST) announced that the Toronto Stock Exchange is reviewing the company’s listing.

    By Adam Jones
  • uploads///Dow Jones
    Cannabis

    Bank of America Upgrades Canopy Growth to ‘Buy’

    Canopy Growth (WEED)(CGC) got a rare upgrade to “buy” from Bank of America today. Find out what drove the change—and what’s next.

    By Adam Jones
  • uploads///Google Oracle
    Cannabis

    Illegal Cannabis: A Big Problem for Legal Producers

    Despite Canada’s legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.

    By Adam Jones
  • uploads///space grey ipad air with graph on brown wooden table
    Cannabis

    Did HEXO Get Itself into a Licensing Scandal?

    Last week, HEXO Corporation (HEXO) issued a press release that provided more information about its Niagara facility license.

    By Adam Jones
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Cannabis

    Canopy Growth: Wall Street’s Recommendations and Price Targets

    Canopy Growth (WEED)(CGC) has been one of the most-watched stocks among investors and analysts alike.

    By Adam Jones
  • uploads///hexo
    Cannabis

    HEXO: Legal Cannabis Might Not Kill Illegal Market

    In the fourth-quarter earnings call, HEXO discussed how it thinks that legal cannabis won’t solve the problem with the illegal market in Canada.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis: Kraft Heinz Marks Warren Buffett’s Entry

    Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

    By Sushree Mohanty
  • uploads///canna_
    Cannabis

    Cannabis Update: HEXO, CTST, APHA, and ACB

    At 12:51 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were up 0.5% and 0.7%, respectively. The cannabis sector was also up today.

    By Rajiv Nanjapla
  • uploads///Nasdaq Crossed Resistance
    Cannabis

    Smokable Hemp: Banned in North Carolina in May 2020

    When May 1, 2020, rolls around, you’ll won’t be able to smoke hemp in North Carolina legally. Just yesterday, the North Carolina House passed the North Carolina Farm Act with revisions to restrict smokable hemp. Why was it banned? The smokable hemp ban was widely supported by law enforcement agencies. Law enforcement officers might find […]

    By Market Realist
  • uploads///AdobeStock_
    Cannabis

    CannTrust Is Up after Falling below $1

    Today CannTrust Holdings is trading at $1.30 on the NYSE, 25.60% higher than its last closing price. It’s risen even faster on the Toronto Stock Exchange.

    By Margaret Patrick
  • uploads///cann
    Cannabis

    Cannabis Stocks in the Green: APHA, WEED, CTST, ACB

    With a boost from Aphria’s (APHA) impressive first-quarter earnings, cannabis stocks and ETFs were trading higher today. Let’s take a closer look.

    By Rajiv Nanjapla
  • uploads///HEXO
    Cannabis

    HEXO: The Next Cannabis Player on the Scandal Radar?

    By the end of September, HEXO was one of the few cannabis companies to have delivered positive returns in 2019. However, this month has been tough.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Scandal Radar: Is Tilray Next?

    Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar?

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: Week Ended October 10 in Review

    The cannabis sector continued its downward movement in the week that ended on October 10, with ETFs and prominent cannabis players falling.

    By Margaret Patrick
  • uploads///Why Scotts Miracle Gro CannTrust and Emerald Health are Surging Today
    Materials

    Miracle-Gro, CannTrust, Emerald Health Stocks Surging

    Scotts Miracle-Gro (SMG) reported its earnings this morning. Now SMG is surging alongside CannTrust and Emerald Health stocks. Here’s why.

    By Adam Jones
  • uploads///SMG Stocks Cannabis Bet Seems to be Paying Off
    Materials

    SMG Stock’s Cannabis Bet Is Paying Off

    SMG stock became hot last year with other core cannabis stocks like Canopy Growth (WEED) (CGC), Aurora Cannabis (ACB), and Tilray (TLRY).

    By Adam Jones
  • uploads///CannTrust
    Cannabis

    CannTrust Stock Hits an All Time Low: What’s Next?

    CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Roundup: KSHB, WEED, CTST, and CURA

    Today, President Trump announced that a US-China trade deal could happen earlier than expected. Equities were up, but cannabis stocks were mixed.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis: House to Vote on US Banking Bill

    The SAFE Banking Act is gaining traction again, as House Majority Leader Steny Hoyer is expected to bring the banking bill to the House floor for a vote.

    By Sushree Mohanty
  • uploads///CannTrust
    Cannabis

    CannTrust Loses License: Will It Fall below $1?

    CannTrust reported that its license under the Cannabis Act was suspended. The company won’t be able to produce cannabis. Will CannTrust fall below $1?.

    By Adam Jones
  • uploads///cannabis_
    Cannabis

    Cannabis Roundup: MMEN, ACB, WEED, and CTST

    Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.

    By Rajiv Nanjapla
  • uploads///CannTrust_
    Cannabis

    CannTrust: Eight Capital Removed Its Target Price

    On Tuesday, Eight Capital removed its target price for CannTrust Holdings due to uncertainty about the risks involved in the company’s future operations.

    By Rajiv Nanjapla
  • uploads///canntrust
    Cannabis

    CannTrust Down Almost 65% in 2019—What’s Next?

    On September 6, CannTrust Holdings (TRST) (CTST) was trading at 2.33 Canadian dollars. This marked a discount of 85% from its 52-week high.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Roundup: CTST, CRON, OGI, ACB, and WEED

    Cannabis ETFs the ETFMG Alternative Harvest ETF and the Horizons Marijuana Life Sciences Index ETF were up 2.0% and 1.7%, respectively, at 1:20 PM today.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    New Cannabis Products to Follow Edibles Legalization

    Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.

    By Sirisha Bhogaraju
  • uploads///Cannabis_
    Cannabis

    Cannabis Roundup: WEED, ACB, ACRGF, and CTST

    News that the US and China plan to revive trade talks in October boosted the US stock market. Most of the cannabis players traded in the green today.

    By Rajiv Nanjapla
  • uploads///HEXO
    Company & Industry Overviews

    HEXO: What’s the Word on the Street?

    HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    CannTrust: The Bad News Keeps Pouring In

    CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Cannabis Legalization: Did President Trump Drop a Hint?

    Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.

    By Sushree Mohanty
  • uploads///Cannabis ETFs
    Financials

    How Cannabis ETFs HMMJ, MJ, TOKE Looked in August

    In the wake of its regulatory scandals, the cannabis sector lagged the equity market in August. YTD, MJ and HMMJ have fallen 3.7% and 1.5%, respectively.

    By Rajiv Nanjapla
  • uploads///Cronos
    Cannabis

    Cronos: What’s the Word on Wall Street?

    Cronos Group (CRON) reported its Q2 results last month. Despite better-than-expected sales, its Q2 losses widened and its stock has fallen 23% since then.

    By Sirisha Bhogaraju
  • uploads///canopy growth
    Cannabis

    Canopy Growth: What to Expect from Its Earnings Today

    Canopy Growth (CGC) (WEED) is scheduled to announce its results for the first quarter of fiscal 2020 after the market closes on Wednesday.

    By Sushree Mohanty
  • uploads///ogi
    Financials

    OrganiGram: Lower Target Price and Valuation Multiple

    Analysts expect OrganiGram to report revenues of 96.9 million Canadian dollars in fiscal 2019 and 206.5 million Canadian dollars in 2020.

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana and Trade War: Will Democrats’ Agenda Intensify?

    The trade war might impact the marijuana industry. The US-China trade war has been an ongoing issue. President Trump imposed tariffs on China in May.

    By Sushree Mohanty
  • uploads///CL
    Cannabis

    Cresco Labs: Target Price and Valuation Multiple

    Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”

    By Rajiv Nanjapla
  • uploads///Jim Cramer
    Cannabis

    HEXO: What Does Jim Cramer Think?

    HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

    By Rajiv Nanjapla
  • uploads///MedMen
    Cannabis

    MedMen Fires Up to Make Marijuana Legal in Florida

    MedMen (MMNFF) (MMEN) closed 1.9% higher on Thursday. The company launched a 2020 ballot initiative called “Make it Legal Florida.”

    By Sushree Mohanty
  • uploads///Beto o rourke
    Cannabis

    Can Marijuana Legalization Spark Beto O’Rourke’s Bid?

    Marijuana reform is central to Beto O’Rourke’s 2020 presidential campaign—how could his agenda that affect the cannabis industry?

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: What Do Buffett and the Richest Americans Think?

    Marijuana is a hot topic right now! From presidential candidates to the wealthiest Americans, everyone is talking about the sector.

    By Sushree Mohanty
  • uploads///cresco labs
    Cannabis

    Why Is Cresco Labs Tanking ahead of Its Q2 Results?

    Cresco Labs (CRLBF) is all set to report its second-quarter results after the market closes today. Cresco stock tanked 6.9% yesterday.

    By Sushree Mohanty
  • uploads///Bill de Blasio
    Cannabis

    Could Bill de Blasio Help the Cannabis Industry?

    In May, NYC mayor Bill de Blasio announced he was running for the 2020 Democratic presidential nomination. Initially, he was against legalizing cannabis.

    By Rajiv Nanjapla
  • uploads///Jim Cramer
    Cannabis

    Jim Cramer: Cronos and Aphria Passed Canopy Growth

    On Tuesday, Jim Cramer stated that Cronos Group and Aphria passed Canopy Growth. Canopy Growth has lost 15.3% of its stock value since its Q1 earnings.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    Cannabis Industry: FBI Investigation Poses Challenges

    The cannabis industry has been in the spotlight this year, and now the FBI is investigating allegations of corruption in this nascent industry.

    By Sushree Mohanty
  • uploads///canopy growth
    Cannabis

    Canopy Growth Earnings Impacted the Cannabis Sector

    Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    MedMen Launches Cannabis Delivery Service in the US

    MedMen (MMNFF) closed almost 6% higher on Monday. The company announced the launch of its new California-wide delivery service for cannabis.

    By Adam Jones
  • uploads///Bernie
    Cannabis

    Bernie Sanders Tweets on Marijuana Legalization

    Bernie Sanders tweeted his support for legalizing marijuana nationally and expunging past marijuana convictions. How could this impact cannabis stocks?

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Canopy Growth Falls to Its Lowest Point in 2019

    Today, Canopy Growth (WEED) (CGC) stock saw its lowest point in 2019. The stock opened at $28.3 but fell to $26.5 in the afternoon.

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Cannabis Industry: FBI and FDA Tighten the Screws

    Cannabis companies face regulatory challenges. Recently, CannTrust (CTST) didn’t comply with Health Canada’s regulations.

    By Sushree Mohanty
  • uploads///Aphria Eyeing CannTrusts Assets
    Materials

    Is Aphria Eyeing CannTrust’s Assets?

    Aphria (APHA) had stellar Q4 earnings results. Its operating metrics significantly improved, turning its bottom line positive.

    By Adam Jones
  • uploads///IIPR
    Materials

    IIPR’s Q2 Earnings Call: Key Takeaways for Investors

    So far, Innovative Industrial Properties (IIPR) stock has been impressive in 2019. The stock has gained almost 126% year-to-date.

    By Sushree Mohanty
  • uploads///cresco labs
    Cannabis

    Cresco Labs Stock Tumbling ahead of Earnings

    Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company’s stock fell 5.3% yesterday.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis Is Upsizing Its Secured Credit Facility

    Aurora Cannabis (ACB) announced that it’s increasing its secured credit facility to 360 million Canadian dollars from $200 million Canadian dollars.

    By Sushree Mohanty
  • uploads///Mike Tyson
    Cannabis

    Why Mike Tyson Is Talking about Cannabis

    CNN reported that heavyweight champion Mike Tyson said they smoke 10 tons of weed, worth about $40,000, at his California marijuana ranch per month.

    By Sushree Mohanty
  • uploads///CTST
    Financials

    CannTrust: Current Target Price and Valuation Multiple

    As of Monday, CannTrust was trading at 3.04 Canadian dollars. The company has lost 53.6% of its stock value since the beginning of July.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Tilray: What to Expect from Its Q2 Earnings Today

    Tilray (TLRY) is scheduled to release its second-quarter results today after the market closes. Lately, Tilray stock has been off the radar.

    By Sushree Mohanty
  • uploads///cresco
    Company & Industry Overviews

    Cresco Labs Lands New York Deal before Earnings

    Cresco Labs is due to report its Q2 earnings on August 21 after the market closes. A week ahead, it received regulatory approval for a New York deal.

    By Sushree Mohanty
  • uploads///More Trouble for CannTrust Stock Plunges
    Cannabis

    CannTrust: More Compliance Issues, Stock Fell

    Early on Monday, CannTrust (CTST) fell almost 26.8%. The development came after Health Canada found more areas that didn’t comply with regulations.

    By Adam Jones
  • uploads///canntrust
    Cannabis

    Why Is CannTrust Falling on Friday?

    CannTrust (CTST), a popular name in the cannabis sector, has been falling on Friday. The stock has fallen 6.2% as of 10:51 AM ET.

    By Sushree Mohanty
  • uploads///Jim Cramer
    Cannabis

    Why Jim Cramer Favors CRON and CGC

    Canopy Growth (CGC) rose 1.5% today while Cronos Group (CRON) fell 3.8%. CNBC host Jim Cramer favors both stocks amid several weed industry scandals.

    By Sushree Mohanty
  • uploads///Joe Biden
    Cannabis

    Joe Biden Wants to Reform Cannabis Laws

    Joe Biden wants to change the criminal justice system because he “believes no one should be in jail because of cannabis use.”

    By Adam Jones
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.